These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 2077255

  • 1. [Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus].
    Kameda K, Kawabata S, Masuda N.
    Kekkaku; 1990 Dec; 65(12):791-803. PubMed ID: 2077255
    [Abstract] [Full Text] [Related]

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 3. [Pyrazinamide-containing initial intensive short course chemotherapy of pulmonary tuberculosis].
    Wada M.
    Kekkaku; 1997 Oct; 72(10):587-95. PubMed ID: 9386358
    [Abstract] [Full Text] [Related]

  • 4. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 5. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M, Chaulet P, Darbyshire JH, Nunn A, Fox W.
    Rev Mal Respir; 1986 Dec; 3(2):73-85. PubMed ID: 3726263
    [Abstract] [Full Text] [Related]

  • 6. [Controlled clinical trial on efficacy of 5-month regimens and whole course intermittent 6-month regimens in treating bacillary pulmonary tuberculosis].
    Chu N, Yan B, Zhu L.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):388-91. PubMed ID: 11326873
    [Abstract] [Full Text] [Related]

  • 7. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [Abstract] [Full Text] [Related]

  • 8. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S, Deivanayagam CN, Rajasekaran S, Venkatesan P, Padmapriyadarsini C, Menon PA, Ponnuraja C, Dilip M.
    Natl Med J India; 2008 Nov; 21(1):3-8. PubMed ID: 18472696
    [Abstract] [Full Text] [Related]

  • 9. [Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].
    Xu WG, Gao Z, Fan BD.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):74-6. PubMed ID: 12783655
    [Abstract] [Full Text] [Related]

  • 10. [Retreatment of pulmonary tuberculosis--duration of chemotherapy].
    Wada M, Seita A, Mori T, Ogata H, Sugie T, Sugita H.
    Kekkaku; 1993 Jul; 68(7):469-78. PubMed ID: 8361115
    [Abstract] [Full Text] [Related]

  • 11. [Research and control of relapse tuberculosis cases].
    Yamagishi F, Toyota M.
    Kekkaku; 2009 Dec; 84(12):767-8. PubMed ID: 20077861
    [Abstract] [Full Text] [Related]

  • 12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 13. [Efficacy of unfixed continuation phase short-course chemotherapy].
    Xiao C, Fu Y, Li Z.
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):358-60. PubMed ID: 10374447
    [Abstract] [Full Text] [Related]

  • 14. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].
    Han JP, Sun SL, Li RZ, Zhang FS, Wang SC, Cheng J, Deng YF, Wang Y, Yu CB.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654
    [Abstract] [Full Text] [Related]

  • 15. [Efficacy of regimens containing INH, RFP with varied chemotherapy courses on retreated culture positive pneumoconio-tuberculosis].
    Jiang W, Chen H, Gao J, Huaibei M.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Nov; 21(11):648-50. PubMed ID: 11477888
    [Abstract] [Full Text] [Related]

  • 16. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 17. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M, Yosiyama T, Yosikawa M, Ogata H, Sugie T, Nakasono T, Sugita H.
    Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
    [Abstract] [Full Text] [Related]

  • 18. Short course chemotherapy for pulmonary tuberculosis in routine service in Kenya.
    Babu Swai O, Aluoch JA, Githui W, Darbyshire JH.
    East Afr Med J; 1990 Nov; 67(11):748-55. PubMed ID: 2076674
    [Abstract] [Full Text] [Related]

  • 19. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
    Teo SK.
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
    [Abstract] [Full Text] [Related]

  • 20. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R.
    Schweiz Med Wochenschr; 1989 Mar 11; 119(10):299-305. PubMed ID: 2652281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.